| Makale Türü |
|
||
| Dergi Adı | Cytotechnology (Q3) | ||
| Dergi ISSN | 0920-9069 Dergi Bilgileri (2026) | ||
| Dergi Tarandığı Indeksler | SCI | ||
| Makale Dili | Türkçe | Basım Tarihi | 01-2026 |
| Kabul Tarihi | 02-01-2026 | Yayınlanma Tarihi | 27-01-2026 |
| Cilt / Sayı / Sayfa | 78 / 1 / 35–0 | DOI | 10.1007/s10616-026-00892-1 |
| Makale Linki | https://pmc.ncbi.nlm.nih.gov/articles/PMC12847529/ | ||
| UAK Araştırma Alanları |
Hücre Biyolojisi
|
||
| Özet |
| It is believed that CSCs, which are resistant to chemotherapy and radiation, develop in certain situations, stay in the tissue niche after treatment, and cause disease recurrence. Targeting these cells, which are thought to be chemoresistant, may enable treatment to eliminate metastasis or recurrence. For this reason, we aimed to isolate CSCs from various breast cancer cell lines using a drug selection method in this study and then identify them via flow cytometry and fluorescent staining. MDA-123, MCF-7, and 4T1 were used as in vitro models, with HUVEC as controls. After isolation of stem cells from these cells by incubation with 5-fluorouracil (5-FU) and cisplatin (Cis), CSCs were identified by flow cytometry using CD24/CD44/CD133/EPCAM by assessing the rhodamine 123 (Rho 123). The results showed that 5-FU and Cis reduced the CD24 receptor in both cancer and normal cells, while the others showed … |
| Anahtar Kelimeler |
| Cancer stem-like cell | CD133 | CD44-CD24 | EpCAM | Rhodamine 123 |
| Atıf Sayıları | |
| Web of Science | 1 |
| Scopus | 1 |
| Google Scholar | 1 |
| Dergi Adı | CYTOTECHNOLOGY |
| Kısa Adı | CYTOTECHNOLOGY |
| Yayıncı | SPRINGER |
| Açık Erişim | Hayır |
| ISSN | 0920-9069 |
| E-ISSN | 1573-0778 |
| Wos Quartile | Q3 |
| Scopus Quartile | Q3 |
| Tarandığı Indeksler | SCIE , Scopus |
| WoS Kategoriler | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELL BIOLOGY |
| Scopus Kategoriler | BIOENGINEERING | BIOMEDICAL ENGINEERING | BIOTECHNOLOGY | CLINICAL BIOCHEMISTRY | CELL BIOLOGY |